Our History
Since our founding in Nashua, New Hampshire in 1987, we鈥檝e been dedicated to solving complex manufacturing challenges. We began as a laser systems integration company before shifting our focus to medical device contract manufacturing. As we鈥檝e grown, we鈥檝e continually expanded our capabilities to support innovation in the MedTech industry.
Passion for Innovation
For over 30 years, 91快活林庐 has led the way in medical device manufacturing. The passion for advanced laser technology that launched the company in 1987 still drives our approach today. Building on our expertise in laser processing, we鈥檝e expanded into a broad range of capabilities, enabling vertical integration and delivering comprehensive manufacturing solutions to solve even the most complex MedTech challenges.
Rapid Growth
Since 2015, 91快活林 has been growing rapidly. Through targeted acquisitions and greenfield investments, we have expanded into a global leader in advanced engineering, prototyping, product development, and micromanufacturing. Each of our locations is focused on specific manufacturing capabilities and technologies that provide a unique solution for the medical device and advanced diagnostic industries.
Our latest news, research, and insights
BLOG
August 26, 2026
Why Battery Longevity Matters More Than Capacity in Implantable Medical Devices
When engineers evaluate a battery,聽it’s聽natural to focus on day-one performance. Higher capacity, strong power output, and impressive energy density can…
Read More BLOG
August 18, 2026
Implantable Medical Device Batteries 101: How to Choose the Right Power Solution
Choosing an implantable medical device battery involves far more than selecting the highest capacity聽option. Battery selection can influence device size,…
Read More
BLOG
August 3, 2026
How聽to聽Accelerate Development of Complex Cardiac Devices: Lessons from VenstraMedical’s Next-Generation Blood Pump聽
Executive Summary聽 Developing a聽catheter-based cardiac support device聽means balancing catheter deliverability, pump performance, anatomical interaction, manufacturability, regulatory requirements, and investor expectations…
Read More